What is the controversy with remdesivir?
•
4 min read
Following its emergency authorization early in the COVID-19 pandemic, the antiviral drug remdesivir was quickly enveloped in controversy, fueled by conflicting clinical trial results and debates over its effectiveness and cost. This public disagreement raised fundamental questions about the evidence base for new treatments during a global health crisis and the role of pharmaceutical companies in a pandemic.
